Cargando…

Prevalence of transient congenital hypothyroidism in central part of Iran

BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Mahmoud, Hashemipour, Mahin, Hovsepian, Silva, Heiydari, Kamal, Sajadi, Ali, Hadian, Rezvaneh, Mansourian, Marjan, Mirshahzadeh, Naghme, Dalvi, Marzie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872610/
https://www.ncbi.nlm.nih.gov/pubmed/24379847
_version_ 1782296989085466624
author Ghasemi, Mahmoud
Hashemipour, Mahin
Hovsepian, Silva
Heiydari, Kamal
Sajadi, Ali
Hadian, Rezvaneh
Mansourian, Marjan
Mirshahzadeh, Naghme
Dalvi, Marzie
author_facet Ghasemi, Mahmoud
Hashemipour, Mahin
Hovsepian, Silva
Heiydari, Kamal
Sajadi, Ali
Hadian, Rezvaneh
Mansourian, Marjan
Mirshahzadeh, Naghme
Dalvi, Marzie
author_sort Ghasemi, Mahmoud
collection PubMed
description BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent CH (PCH). MATERIALS AND METHODS: In this cross-sectional study, children with primary diagnosis of CH were studied. Considering screening and follow-up lab data and the decision of pediatric endocrinologists, the final diagnosis of TCH was determined. RESULTS: A total of 464,648 neonates were screened. The coverage percent of the CH screening and recall rate was 98.9 and 2.1%, respectively. Out of which, 1,990 neonates were diagnosed with primary CH. TCH was diagnosed in 1,580 neonates. The prevalence of TCH was 1 in 294 live births. 79.4% of patients with primary CH had TCH. Mean of screening (54.7 ± 59.0 in PCH vs 21.8 ± 28.9 in TCH), recall (56.5 ± 58.8 in PCH vs 36.6 ± 45.0 in TCH), and thyroid stimulating hormone (TSH) and mean of TSH before (2.0 ± 2.9 in PCH vs 1.6 ± 1.6 in TCH) and after (37.7 ± 29.5 in PCH vs 4.3 ± 1.9 in TCH) discontinuing treatment at 3 years of age was significantly higher in PCH than TCH (P < 0.0000). CONCLUSION: The higher rate of CH in Isfahan is mainly due to the transient form of the disease. Further studies for evaluating the role of other environmental, autoimmune and/or genetic factors in the pathophysiology of the disease is warranted.
format Online
Article
Text
id pubmed-3872610
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38726102013-12-30 Prevalence of transient congenital hypothyroidism in central part of Iran Ghasemi, Mahmoud Hashemipour, Mahin Hovsepian, Silva Heiydari, Kamal Sajadi, Ali Hadian, Rezvaneh Mansourian, Marjan Mirshahzadeh, Naghme Dalvi, Marzie J Res Med Sci Original Article BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent CH (PCH). MATERIALS AND METHODS: In this cross-sectional study, children with primary diagnosis of CH were studied. Considering screening and follow-up lab data and the decision of pediatric endocrinologists, the final diagnosis of TCH was determined. RESULTS: A total of 464,648 neonates were screened. The coverage percent of the CH screening and recall rate was 98.9 and 2.1%, respectively. Out of which, 1,990 neonates were diagnosed with primary CH. TCH was diagnosed in 1,580 neonates. The prevalence of TCH was 1 in 294 live births. 79.4% of patients with primary CH had TCH. Mean of screening (54.7 ± 59.0 in PCH vs 21.8 ± 28.9 in TCH), recall (56.5 ± 58.8 in PCH vs 36.6 ± 45.0 in TCH), and thyroid stimulating hormone (TSH) and mean of TSH before (2.0 ± 2.9 in PCH vs 1.6 ± 1.6 in TCH) and after (37.7 ± 29.5 in PCH vs 4.3 ± 1.9 in TCH) discontinuing treatment at 3 years of age was significantly higher in PCH than TCH (P < 0.0000). CONCLUSION: The higher rate of CH in Isfahan is mainly due to the transient form of the disease. Further studies for evaluating the role of other environmental, autoimmune and/or genetic factors in the pathophysiology of the disease is warranted. Medknow Publications & Media Pvt Ltd 2013-08 /pmc/articles/PMC3872610/ /pubmed/24379847 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ghasemi, Mahmoud
Hashemipour, Mahin
Hovsepian, Silva
Heiydari, Kamal
Sajadi, Ali
Hadian, Rezvaneh
Mansourian, Marjan
Mirshahzadeh, Naghme
Dalvi, Marzie
Prevalence of transient congenital hypothyroidism in central part of Iran
title Prevalence of transient congenital hypothyroidism in central part of Iran
title_full Prevalence of transient congenital hypothyroidism in central part of Iran
title_fullStr Prevalence of transient congenital hypothyroidism in central part of Iran
title_full_unstemmed Prevalence of transient congenital hypothyroidism in central part of Iran
title_short Prevalence of transient congenital hypothyroidism in central part of Iran
title_sort prevalence of transient congenital hypothyroidism in central part of iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872610/
https://www.ncbi.nlm.nih.gov/pubmed/24379847
work_keys_str_mv AT ghasemimahmoud prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT hashemipourmahin prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT hovsepiansilva prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT heiydarikamal prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT sajadiali prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT hadianrezvaneh prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT mansourianmarjan prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT mirshahzadehnaghme prevalenceoftransientcongenitalhypothyroidismincentralpartofiran
AT dalvimarzie prevalenceoftransientcongenitalhypothyroidismincentralpartofiran